Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales: Herman, SEM, Barr, PM, McAuley, EM, Liu, D, Wiestner, A, Friedberg, JW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920486/
https://www.ncbi.nlm.nih.gov/pubmed/23385377
http://dx.doi.org/10.1038/leu.2013.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920486/
https://www.ncbi.nlm.nih.gov/pubmed/23385377
http://dx.doi.org/10.1038/leu.2013.37

Ejemplares similares